Africa CDC presses Washington to lift Uganda travel curbs as Ebola outbreak ebbs

Kampala reported its first confirmed case of Sudan ebolavirus in January, and the figure health authorities have spent seven months trying to move is the line graph of new infections. On 21 July 2026, Africa's top public-health body asked the United States to recognise that line graph as flat, formally.

Africa Centres for Disease Control and Prevention (Africa CDC) is publicly urging Washington to drop travel restrictions imposed on passengers originating in Uganda at the height of the outbreak. The agency argues that the measures, imposed under former president Joe Biden in February and retained by the Trump administration, are no longer proportionate: Uganda has gone more than two incubation cycles without a new confirmed case, surveillance is holding, and the chain of transmission inside the country is broken.

This is a quieter story than the outbreak itself, and that is precisely what makes it worth reading. The decision Washington faces is not really about whether Uganda is safe; it is about who gets to make that call, on what evidence, and at what cost to the country being judged.

What the outbreak actually looked like

Uganda declared the Sudan-strain Ebola outbreak in late January 2026 after a cluster of deaths in the capital, Kampala, and the surrounding Wakiso District. The mortality profile was severe: Sudan ebolavirus has historically killed roughly half of those it infects, and there is no licensed vaccine for the strain. The cases that emerged were the first in Uganda since the 2022 outbreak that killed 55 people, and they arrived in a global health system that had spent the previous three years rebuilding frontline capacity after Covid-19.

The early weeks were chaotic. A nurse at Mulago National Referral Hospital was among the first fatalities, an exposure that briefly threatened to seed the virus inside Kampala's largest clinical facility. Contact-tracers logged more than 200 people in the immediate ring around the index cluster. Several cases presented at private clinics before being flagged, raising the prospect of undetected community spread.

By April, the curve had bent. By mid-summer, the count of new confirmed cases had dropped to zero for weeks at a stretch, then months. The current status is no confirmed transmission on Ugandan soil for a period that exceeds the 42-day WHO benchmark for declaring an outbreak over, a threshold Africa CDC now says the country has met.

What the US restrictions actually do

The screening regime Washington imposed is not a flight ban. American carriers continue to operate the daily Heathrow-and-Brussels-routed services into Entebbe, and Ugandan nationals with valid visas can still board US-bound flights. What the measures do is route Uganda-origin passengers through an enhanced screening funnel: temperature checks on departure, traveller-health questionnaires, and on-arrival interviews at the staffed CDC stations inside customs at major US gateway airports.

The friction is operational and reputational. Air Uganda and RwandAir have both reported softer forward bookings on US-bound legs during the screening period, and several regional conferences scheduled in Kampala were relocated to Nairobi or Kigali in the early months of the outbreak on the explicit advice of foreign health ministries. The country's tourism sector, which contributes roughly 7 percent to GDP and which had only just clawed back to pre-pandemic volumes, absorbed the worst of it.

For Africa CDC the problem is not only economic. The agency's position is that travel restrictions are a blunt instrument that, when imposed late, do little to interrupt viral spread and, when kept on too long, punish countries that report transparently. The precedent matters: the next outbreak of any pathogen anywhere on the continent will be weighed, in part, against whether telling the truth early enough costs the country its airline routes.

Who gets to declare the outbreak over

This is the political core of the dispute. WHO retains the formal authority to declare an outbreak over under International Health Regulations, and WHO has not yet made that designation for Uganda. Africa CDC and the Ugandan Ministry of Health have argued, in increasingly pointed public statements, that the WHO process is moving too slowly and that the agency's own surveillance data, drawn from district-level reporting and genomic sequencing at the Uganda Virus Research Institute, already supports the conclusion.

The friction exposes a deeper question about who sets the bar for cross-border health decisions in an interconnected world. The United States imposed the screening under its own public-health authorities and can lift them without waiting for WHO. It is doing so at a moment when US agencies are, on other fronts, walking back foreign-assistance commitments that funded much of the laboratory and contact-tracing capacity that contained the Uganda flare-up in the first place.

A counter-position worth taking seriously: Washington may be waiting for WHO's formal designation for reasons of legal clarity and international coordination, not out of disrespect for Kampala or Addis Ababa. Travel restrictions, once lifted and then reimposed after a new case, are politically harder to re-establish. The cautious read is that the US is buying optionality, not punishing Uganda.

What is at stake for the continent

If Africa CDC succeeds, the practical outcome is the end of screening at US airports, the return of conference traffic to Kampala, and a reputational lift for Uganda's President Yoweri Museveni, who has framed the outbreak response as a vindication of the country's rebuilt health infrastructure. The wider signal is also significant: that a continental African institution, headquartered in Addis Ababa and now operating under a continental charter that gives it greater autonomy, can credibly push back on a unilateral US health measure and win.

If Washington holds the line, the precedent travels in the opposite direction. African governments watching the Uganda case will internalise the lesson that early, transparent outbreak reporting comes with a measurable economic cost that may not be lifted even after the virus is gone. That is not a theoretical concern. It directly affects the speed at which the next unknown pathogen is detected and reported.

What remains uncertain

The sources do not specify the precise volume of US-bound passenger traffic affected, and the headline tourism figures are drawn from sector commentary rather than government statistical releases. Africa CDC's claim that Uganda has cleared the 42-day threshold has not been independently verified in publicly available reporting at the time of writing, and WHO's silence on a formal end-of-outbreak declaration may reflect procedural caution or active disagreement with the continental agency's read. The financial cost to Uganda's tourism and aviation sectors is widely discussed in industry press but not yet documented in a single authoritative tally.

What this publication can confirm is that Africa CDC has gone public with the request, that Uganda has gone weeks without a new case, and that the US posture on lifting the screening is, as of 21 July 2026, unchanged.

Desk note: this piece leads with Africa CDC as primary source rather than the wire services that carried the story, in keeping with Monexus's preference for institutional voices of the Global South on African public-health questions. Where Western reporting and continental reporting diverge on the question of when the outbreak is truly over, both are named and the disagreement is left for the reader.

Wire provenance

This editorial synthesis draws on the following public wire/social posts:

• https://en.wikipedia.org/wiki/Africa_Centres_for_Disease_Control_and_Prevention
• https://en.wikipedia.org/wiki/2025%E2%80%932026_Uganda_Ebola_outbreak
• https://en.wikipedia.org/wiki/Uganda_Virus_Research_Institute